BI
BiomeSense, Inc.
SEC filingBiotechnology · Chicago, IL
Amount raised$7.1Msold at filing
Total offering$7.3M$190K still open
Investors in the raise27count reported to the SEC
FiledNov 3, 2025first sale Jul 18, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Dylan NicholsDirector
Ashley HartmanDirector
Kevin HonakerExecutive Officer, Director
Vanessa Rollings GiannisDirector
Andrew BluesteinDirector
Executive officers, directors and promoters as listed on the Form D.